These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 9140026)

  • 21. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
    Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents.
    Schwartz GJ; McHugh PR; Moran TH
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R303-8. PubMed ID: 8048636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic secretion stimulated by CCK is not mediated by capsaicin-sensitive vagal afferent pathway in awake rats.
    Guan D; Phillips WT; Green GM
    Am J Physiol; 1996 May; 270(5 Pt 1):G881-6. PubMed ID: 8967501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin/Cholecystokinin-1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates inflammation in rats.
    Lubbers T; de Haan JJ; Luyer MD; Verbaeys I; Hadfoune M; Dejong CH; Buurman WA; Greve JW
    Ann Surg; 2010 Aug; 252(2):376-82. PubMed ID: 20585240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion.
    Li Y; Owyang C
    J Clin Invest; 1993 Jul; 92(1):418-24. PubMed ID: 8100836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.
    Reidelberger RD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1354-8. PubMed ID: 1481948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vagal afferent-dependent cholecystokinin modulation of visceral pain requires central amygdala NMDA-NR2B receptors in rats.
    Wang EM; Li WT; Yan XJ; Chen X; Liu Q; Feng CC; Cao ZJ; Fang JY; Chen SL
    Neurogastroenterol Motil; 2015 Sep; 27(9):1333-43. PubMed ID: 26197883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of food intake by GI fatty acid infusions: roles of celiac vagal afferents and cholecystokinin.
    Cox JE; Kelm GR; Meller ST; Randich A
    Physiol Behav; 2004 Aug; 82(1):27-33. PubMed ID: 15234586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components.
    Hommer DW; Palkovits M; Crawley JN; Paul SM; Skirboll LR
    J Neurosci; 1985 Jun; 5(6):1387-92. PubMed ID: 4009236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Vagotomy and Sympathectomy on the Feeding Responses Evoked by Intra-Aortic Cholecystokinin-8 in Adult Male Sprague Dawley Rats.
    Mhalhal TR; Washington MC; Heath JC; Sayegh AI
    Endocr Res; 2021; 46(2):57-65. PubMed ID: 33426974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of vagal afferent responses to duodenal loads and exogenous CCK in rats.
    Schwartz GJ; Tougas G; Moran TH
    Peptides; 1995; 16(4):707-11. PubMed ID: 7479306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vagal mediation of the cholecystokinin satiety effect in rats.
    Lorenz DN; Goldman SA
    Physiol Behav; 1982 Oct; 29(4):599-604. PubMed ID: 6294698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The feeding responses evoked by cholecystokinin are mediated by vagus and splanchnic nerves.
    Brown TA; Washington MC; Metcalf SA; Sayegh AI
    Peptides; 2011 Aug; 32(8):1581-6. PubMed ID: 21745513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric branch vagotomy blocks nutrient and cholecystokinin-induced suppression of gastric emptying.
    Schwartz GJ; Berkow G; McHugh PR; Moran TH
    Am J Physiol; 1993 Mar; 264(3 Pt 2):R630-7. PubMed ID: 8457019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake.
    Weatherford SC; Ritter S
    Physiol Behav; 1988; 43(5):645-50. PubMed ID: 3200921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subdiaphragmatic vagal deafferentation fails to block the anorectic effect of hydroxycitrate.
    Leonhardt M; Hrupka BJ; Langhans W
    Physiol Behav; 2004 Sep; 82(2-3):263-8. PubMed ID: 15276787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vagal nerve stimulation activates vagal afferent fibers that reduce cardiac efferent parasympathetic effects.
    Yamakawa K; Rajendran PS; Takamiya T; Yagishita D; So EL; Mahajan A; Shivkumar K; Vaseghi M
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1579-90. PubMed ID: 26371172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin.
    Peters JH; Karpiel AB; Ritter RC; Simasko SM
    Endocrinology; 2004 Aug; 145(8):3652-7. PubMed ID: 15105382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for selective section of vagal afferent or efferent axons in the rat.
    Norgren R; Smith GP
    Am J Physiol; 1994 Oct; 267(4 Pt 2):R1136-41. PubMed ID: 7524370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of afferent and efferent denervation of vagal nerve on endotoxin-induced oxidative stress in rats.
    Abdel-Salam OM; Abdel-Rahman RF; Sleem AA; Mosry FA; Sharaf HA
    J Neural Transm (Vienna); 2013 Dec; 120(12):1673-88. PubMed ID: 23794033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.